Bryant Su

Bryant Su is currently an unknown role at Check. Prior to that, they were a software engineer at Capital One from February 2018 to March 2021. Their focus there was understanding the abnormal accumulation of the protein alpha-synuclein in diseases like Parkinson’s. Bryant was responsible for handling Western Blots, immunoprecipitation protocols, and other wet lab procedures, passaging, storing, and testing various cell lines, i.e. HEK293 and MIN6, and managed inventory of supplies and materials for the lab. Their principal investigator was Tritia Yamasaki, M.D., Ph.D.

Before that, they were a laboratory technician with Yamasaki Lab at the University of Kentucky from August 2017 to December 2017. Their focus there was also understanding the abnormal accumulation of the protein alpha-synuclein in diseases like Parkinson’s. Their responsibilities were similar to their role at Capital One, including handling Western Blots, immunoprecipitation protocols, and other wet lab procedures, passaging, storing, and testing various cell lines, i.e. HEK293 and MIN6, and managed inventory of supplies and materials for the lab. Their principal investigator was again Tritia Yamasaki, M.D., Ph.D.

Prior to that, they were an undergraduate researcher with Wang Lab at the University of North Carolina at Chapel Hill from June 2014 to January 2017.

Bryant Su has a Master's degree in Computer Science from the Georgia Institute of Technology and a Bachelor's Degree in Biomedical/Medical Engineering from the University of North Carolina at Chapel Hill.